National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

BEACOPP regimen
A chemotherapy regimen consisting of bleomycin, etoposide, doxorubicin hydrochloride (Adriamycin), cyclophosphamide, vincristine (Oncovin), procarbazine and prednisone, used for the treatment of advanced-stage Hodgkin lymphoma. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Bleomycin-Etoposide-Adriamycin-Cyclophosphamide-Oncovin-Procarbazine-Prednisone regimen



Previous:BCG vaccine, bcr-abl (b2a2)-derived peptide vaccine, bcr-abl (b3a2)-derived peptide vaccine, bcr-abl p210-b3a2 breakpoint-derived multipeptide vaccine, bcr-abl peptide vaccine
Next:Bead Block Compressible Microspheres, becatecarin, Becenum, beclomethasone dipropionate, Beclovent

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov